The pathophysiological features of neurotrauma, including traumatic brain injury (TBI) and spinal cord injury, involve a primary mechanical injury that reflects the complex interplay of contusion, compression, and shear and rotational forces as well as a series of vascular, metabolic, molecular, and inflammatory processes that synergistically culminate in a process termed secondary injury. 2, 5, 8, 9 Although improved outcomes after TBI have occurred due to the use of restraint systems in automobiles, protocol-driven critical care management, and judicious use of decompressive surgery, no significant attenuation of secondary injury mechanisms has yet occurred in the clinical setting, despite promising data from animal models.
Although improved outcomes after TBI have occurred due to the use of restraint systems in automobiles, protocol-driven critical care management, and judicious use of decompressive surgery, no significant attenuation of secondary injury mechanisms has yet occurred in the clinical setting, despite promising data from animal models.
There are persuasive data implicating mitochondrial dysfunction and delayed apoptosis or programmed cell death in the pathobiological mechanisms of neuronal cell death after TBI. Based on some animal models and preliminary clinical data, it has been postulated that impairments in oxygen delivery and extraction could be involved in the mechanism of posttraumatic mitochondrial dysfunction in neurons. 1, 7 With this background implying that hyperoxic therapy could improve cerebral metabolism after TBI, Diringer and colleagues have examined the effect of 100% oxygen on cerebral metabolism and cerebral blood flow by using positron emission tomography scanning techniques. Five patients with TBI (median Glasgow Coma Scale Score 7; range 3-9) were studied within 24 hours of injury (mean time 17.9 hours posttrauma). Patients received 1 hour of 100% fraction of inspired O 2 , before and after which hemodynamic and blood gas measurements were obtained. No significant changes in cerebral blood flow, intracranial pressure, oxygen extraction fraction, or global cerebral metabolic rate for oxygen (CMRO 2 ) were observed during the trial of hyperoxic therapy.
These data call into question the role of hyperoxic therapy as a treatment approach for TBI. 3, 4, 6 However, as acknowledged by the authors, this study has a number of important limitations. The sample size of five patients was limited. Moreover, no patients were studied fewer than 12 hours after TBI, hyperbaric oxygen was not tested, and CMRO 2 was only measured after 1 hour. Thus, the authors cannot exclude the possibility that a more robust response would be seen at a later time with hyperoxic therapy. It is also possible that hyperoxic therapy may improve outcome in severe TBI through mechanisms that are not reflected in a measurable increase in CMRO 2 .
Despite these limitations, the authors are to be congratulated for undertaking these complex physiological assessments of the effect of hyperoxic therapy on TBI using "gold standard" positron emission tomography scanning methodology. Although this study does not definitively exclude a potential role for hyperoxic therapy in which hyperbaric approaches are used at later time points, the absence of even a trend in physiological benefit from hyperoxic therapy does call into question this therapeutic modality. Further clinical research is required to establish whether hyperoxic therapy is of value in TBI.
